ARGENT: exploring nano solutions to cancer therapy


The new FP7 European Multi-ITN (Marie Curie Action Initial Training Network) Project “Advanced Radiotherapy, Generated by Exploiting Nanoprocesses and Technologies (FP7 ITN ARGENT)” has been started in March 2014.

The main objective of this intersectorial and multidisciplinary ITN is to create a new generation of researchers and experts able to develop and propose to the society new tools and concepts for the improvement of cancer therapy treatments’’ The consortium aims to train a cohort of 13 PhDs (Early Stage Researchers – ESRs) to subsequently act as leaders and ambassadors in the field. The ITN ARGENT strategy relies i) on improving our understanding of the processes and mechanisms underlying radiation damage on a nanoscopic level, ii) on the application of the improved know-how in the production and development of functionalised nanodrugs to amplify the effects of medical beams and iii) on the developments of concepts and codes for clinical applications taking into account the new information. Read more...